APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pets Parasiticide Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pets Parasiticide Medicines Market Outlook and Growth Opportunities 2026

2 January 2026197 pages

Choose your research edition.

Industry ResearchPets Parasiticide Medicines Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Pets Parasiticide Medicines Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Pets Parasiticide Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pets Parasiticide Medicines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pets Parasiticide Medicines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pets Parasiticide Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pets Parasiticide Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pets Parasiticide Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pets Parasiticide Medicines market include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Vetoquinol, Virbac, Zoetis, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pets Parasiticide Medicines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pets Parasiticide Medicines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pets Parasiticide Medicines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pets Parasiticide Medicines market.

Pets Parasiticide Medicines Segment by Company

Bimeda Animal Health

Boehringer Ingelheim

Ceva Sante Animale

Elanco

Vetoquinol

Virbac

Zoetis

Bayer

Merck

Pets Parasiticide Medicines Segment by Type

In Vitro Parasiticide Medicines

In Vivo Parasiticide Medicines

Pets Parasiticide Medicines Segment by Application

Cats

Equine

Dogs

Others

Pets Parasiticide Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pets Parasiticide Medicines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pets Parasiticide Medicines key companies, revenue, market share, and recent developments.

3. To split the Pets Parasiticide Medicines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pets Parasiticide Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pets Parasiticide Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze Pets Parasiticide Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Parasiticide Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pets Parasiticide Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Parasiticide Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pets Parasiticide Medicines industry.

Chapter 3: Detailed analysis of Pets Parasiticide Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pets Parasiticide Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pets Parasiticide Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pets Parasiticide Medicines Industry Trends Table 2. Pets Parasiticide Medicines Industry Drivers Table 3. Pets Parasiticide Medicines Industry Opportunities and Challenges Table 4. Pets Parasiticide Medicines Industry Restraints Table 5. Global Pets Parasiticide Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pets Parasiticide Medicines Revenue Share by Company (2021-2026) Table 7. Global Pets Parasiticide Medicines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pets Parasiticide Medicines Key Company Manufacturing Base & Headquarters Table 9. Global Pets Parasiticide Medicines Company, Product Type & Application Table 10. Global Pets Parasiticide Medicines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pets Parasiticide Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In Vitro Parasiticide Medicines Table 15. Significant Companies of In Vivo Parasiticide Medicines Table 16. Global Pets Parasiticide Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pets Parasiticide Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pets Parasiticide Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pets Parasiticide Medicines Sales Value Share by Type (2021-2026) Table 20. Global Pets Parasiticide Medicines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cats Table 22. Significant Companies of Equine Table 23. Significant Companies of Dogs Table 24. Significant Companies of Others Table 25. Global Pets Parasiticide Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pets Parasiticide Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pets Parasiticide Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pets Parasiticide Medicines Sales Value Share by Application (2021-2026) Table 29. Global Pets Parasiticide Medicines Sales Value Share by Application (2027-2032) Table 30. Global Pets Parasiticide Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pets Parasiticide Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pets Parasiticide Medicines Sales Value Share by Region (2021-2026) Table 33. Global Pets Parasiticide Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pets Parasiticide Medicines Sales Value Share by Region (2027-2032) Table 35. Global Pets Parasiticide Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pets Parasiticide Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pets Parasiticide Medicines Sales Value Market Share by Country (2021-2026) Table 38. Global Pets Parasiticide Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pets Parasiticide Medicines Sales Value Market Share by Country (2027-2032) Table 40. Bimeda Animal Health Company Information Table 41. Bimeda Animal Health Business Overview Table 42. Bimeda Animal Health Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio Table 44. Bimeda Animal Health Recent Development Table 45. Boehringer Ingelheim Company Information Table 46. Boehringer Ingelheim Business Overview Table 47. Boehringer Ingelheim Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio Table 49. Boehringer Ingelheim Recent Development Table 50. Ceva Sante Animale Company Information Table 51. Ceva Sante Animale Business Overview Table 52. Ceva Sante Animale Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio Table 54. Ceva Sante Animale Recent Development Table 55. Elanco Company Information Table 56. Elanco Business Overview Table 57. Elanco Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Elanco Pets Parasiticide Medicines Product Portfolio Table 59. Elanco Recent Development Table 60. Vetoquinol Company Information Table 61. Vetoquinol Business Overview Table 62. Vetoquinol Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Vetoquinol Pets Parasiticide Medicines Product Portfolio Table 64. Vetoquinol Recent Development Table 65. Virbac Company Information Table 66. Virbac Business Overview Table 67. Virbac Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Virbac Pets Parasiticide Medicines Product Portfolio Table 69. Virbac Recent Development Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Zoetis Pets Parasiticide Medicines Product Portfolio Table 74. Zoetis Recent Development Table 75. Bayer Company Information Table 76. Bayer Business Overview Table 77. Bayer Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bayer Pets Parasiticide Medicines Product Portfolio Table 79. Bayer Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Pets Parasiticide Medicines Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merck Pets Parasiticide Medicines Product Portfolio Table 84. Merck Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Pets Parasiticide Medicines Product Image Figure 2. Global Pets Parasiticide Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pets Parasiticide Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Pets Parasiticide Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In Vitro Parasiticide Medicines Image Figure 8. In Vivo Parasiticide Medicines Image Figure 9. Global Pets Parasiticide Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pets Parasiticide Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pets Parasiticide Medicines Sales Value Share by Type (2021-2032) Figure 12. Cats Image Figure 13. Equine Image Figure 14. Dogs Image Figure 15. Others Image Figure 16. Global Pets Parasiticide Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pets Parasiticide Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pets Parasiticide Medicines Sales Value Share by Application (2021-2032) Figure 19. Global Pets Parasiticide Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pets Parasiticide Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pets Parasiticide Medicines Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pets Parasiticide Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pets Parasiticide Medicines Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pets Parasiticide Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pets Parasiticide Medicines Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pets Parasiticide Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pets Parasiticide Medicines Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pets Parasiticide Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pets Parasiticide Medicines Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pets Parasiticide Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Parasiticide Medicines
  • In Vivo Parasiticide Medicines
Applications
  • Cats
  • Equine
  • Dogs
  • Others
Companies covered
  • Bimeda Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Elanco
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pets Parasiticide Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pets Parasiticide Medicines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pets Parasiticide Medicines Market Dynamics
  1. 2.1 Pets Parasiticide Medicines Industry Trends
  2. 2.2 Pets Parasiticide Medicines Industry Drivers
  3. 2.3 Pets Parasiticide Medicines Industry Opportunities and Challenges
  4. 2.4 Pets Parasiticide Medicines Industry Restraints
3 Pets Parasiticide Medicines Market by Company
  1. 3.1 Global Pets Parasiticide Medicines Company Revenue Ranking in 2025
  2. 3.2 Global Pets Parasiticide Medicines Revenue by Company (2021-2026)
  3. 3.3 Global Pets Parasiticide Medicines Company Ranking (2024-2026)
  4. 3.4 Global Pets Parasiticide Medicines Company Manufacturing Base and Headquarters
  5. 3.5 Global Pets Parasiticide Medicines Company Product Type and Application
  6. 3.6 Global Pets Parasiticide Medicines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pets Parasiticide Medicines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pets Parasiticide Medicines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pets Parasiticide Medicines Market by Type
  1. 4.1 Pets Parasiticide Medicines Type Introduction
  2. 4.1.1 In Vitro Parasiticide Medicines
  3. 4.1.2 In Vivo Parasiticide Medicines
  4. 4.2 Global Pets Parasiticide Medicines Sales Value by Type
  5. 4.2.1 Global Pets Parasiticide Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pets Parasiticide Medicines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pets Parasiticide Medicines Sales Value Share by Type (2021-2032)
5 Pets Parasiticide Medicines Market by Application
  1. 5.1 Pets Parasiticide Medicines Application Introduction
  2. 5.1.1 Cats
  3. 5.1.2 Equine
  4. 5.1.3 Dogs
  5. 5.1.4 Others
  6. 5.2 Global Pets Parasiticide Medicines Sales Value by Application
  7. 5.2.1 Global Pets Parasiticide Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pets Parasiticide Medicines Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pets Parasiticide Medicines Sales Value Share by Application (2021-2032)
6 Pets Parasiticide Medicines Regional Value Analysis
  1. 6.1 Global Pets Parasiticide Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pets Parasiticide Medicines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pets Parasiticide Medicines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pets Parasiticide Medicines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pets Parasiticide Medicines Sales Value (2021-2032)
  7. 6.3.2 North America Pets Parasiticide Medicines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pets Parasiticide Medicines Sales Value (2021-2032)
  10. 6.4.2 Europe Pets Parasiticide Medicines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pets Parasiticide Medicines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pets Parasiticide Medicines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pets Parasiticide Medicines Sales Value (2021-2032)
  16. 6.6.2 South America Pets Parasiticide Medicines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pets Parasiticide Medicines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pets Parasiticide Medicines Sales Value Share by Country, 2025 VS 2032
7 Pets Parasiticide Medicines Country-level Value Analysis
  1. 7.1 Global Pets Parasiticide Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pets Parasiticide Medicines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pets Parasiticide Medicines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pets Parasiticide Medicines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pets Parasiticide Medicines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pets Parasiticide Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pets Parasiticide Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bimeda Animal Health
  2. 8.1.1 Bimeda Animal Health Company Information
  3. 8.1.2 Bimeda Animal Health Business Overview
  4. 8.1.3 Bimeda Animal Health Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bimeda Animal Health Pets Parasiticide Medicines Product Portfolio
  6. 8.1.5 Bimeda Animal Health Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Pets Parasiticide Medicines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Ceva Sante Animale
  14. 8.3.1 Ceva Sante Animale Company Information
  15. 8.3.2 Ceva Sante Animale Business Overview
  16. 8.3.3 Ceva Sante Animale Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Sante Animale Pets Parasiticide Medicines Product Portfolio
  18. 8.3.5 Ceva Sante Animale Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Pets Parasiticide Medicines Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Vetoquinol
  26. 8.5.1 Vetoquinol Company Information
  27. 8.5.2 Vetoquinol Business Overview
  28. 8.5.3 Vetoquinol Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol Pets Parasiticide Medicines Product Portfolio
  30. 8.5.5 Vetoquinol Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Pets Parasiticide Medicines Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Zoetis
  38. 8.7.1 Zoetis Company Information
  39. 8.7.2 Zoetis Business Overview
  40. 8.7.3 Zoetis Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zoetis Pets Parasiticide Medicines Product Portfolio
  42. 8.7.5 Zoetis Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Pets Parasiticide Medicines Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Pets Parasiticide Medicines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Pets Parasiticide Medicines Product Portfolio
  54. 8.9.5 Merck Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst